Posted in | News | Iron Ore

Xstrata Targets Sphere Minerals

Xstrata may make an unconditional offer for Sphere Minerals Ltd (ASX:SPH) at $428 million if it manages to gain a 50% stake in the company as per Xstrata Coal chief executive Peter Freyberg.

The Swiss mining giant is currently trying to get Sin Tan Development Pte Ltd to sell its 10.77 % stake in Sphere Minerals.

However the Singapore based company said on Wednesday that it was not interested in selling its share in Sphere Minerals to Xstrata. In response Xstrata said that it would allow the $2.50 per share bid to lapse if it failed to gain a controlling stake in Sphere Minerals.

Sphere Minerals Ltd is a Mauritania-focused iron ore mine developer in which Xstrata at present has about 8% stake. Of this more than 5% has been committed by the board of directors of Sphere Minerals.

It is also believed that Sin Tan Development is planning a China backed proposal to fund the Askaf iron ore project in Mauritania in exchange for equity in the project.

The directors of Sphere Minerals have recommended that shareholders accept the offer unless a more lucrative offer emerges.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 18). Xstrata Targets Sphere Minerals. AZoMining. Retrieved on November 22, 2024 from https://www.azomining.com/News.aspx?newsID=984.

  • MLA

    Chai, Cameron. "Xstrata Targets Sphere Minerals". AZoMining. 22 November 2024. <https://www.azomining.com/News.aspx?newsID=984>.

  • Chicago

    Chai, Cameron. "Xstrata Targets Sphere Minerals". AZoMining. https://www.azomining.com/News.aspx?newsID=984. (accessed November 22, 2024).

  • Harvard

    Chai, Cameron. 2019. Xstrata Targets Sphere Minerals. AZoMining, viewed 22 November 2024, https://www.azomining.com/News.aspx?newsID=984.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.